AMELUZ FDA approval date

The FDA approved AMELUZ on 10 May 2016.

FDA approval date
10 May 2016

Drug identity has not yet been verified against registry records

Also recorded as AMINOLEVULINIC ACID HYDROCHLORIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2016-05-10DayAMELUZFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA208081", "applicant_as_listed_by_fda": "BIOFRONTERA", "brand_names": ["AMELUZ"], "active_ingredients": ["AMINOLEVULINIC ACID HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20160510", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026